Last reviewed · How we verify
NCT04394455
Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms
NA trial testing Brief cognitive behavioral therapy in Anxiety in 236 participants. Status unknown.
30 November 2020
Quick facts
| Lead sponsor | Universidad Nacional Autonoma de Honduras |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 236 |
| Start date | 30 June 2020 |
| Primary completion | 30 November 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across Honduras |
Drugs / interventions tested
- Brief cognitive behavioral therapy
- Crisis intervention therapy
Conditions studied
- Anxiety — all drugs for Anxiety →
- Depressive Symptoms — all drugs for Depressive Symptoms →
- Post Traumatic Stress Symptoms — all drugs for Post Traumatic Stress Symptoms →
- Perceived Stress — all drugs for Perceived Stress →
Sponsor
Universidad Nacional Autonoma de Honduras — full company profile →
Who can join
18 and older, any sex, with Anxiety or Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this randomized controlled trial is to determine the effect of two behavioral interventions: brief cognitive-behavioral therapy and crisis intervention therapy through telepsychiatry, over the level of perceived stress, anxiety, depression and post-traumatic stress symptoms during the COVID-19 pandemic in medical residents and medical staff at three hospitals in two cities of Honduras.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04394455
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Universidad Nacional Autonoma de Honduras trials
Trials by the same sponsor.
- NCT07428317 — Use of Lubricant Gel to Shorten the Second Stage of Labor During Vaginal Delivery · NA · recruiting
- NCT07418151 — Effect of Maternal Chocolate Consumption on Fetal Non-Stress Test (NST) Reactivity. · NA · recruiting
- NCT07440069 — Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor · Phase 4 · recruiting
- NCT07411352 — Left Lateral Position vs Supine Position to Reduce Active Labor Duration · NA · recruiting
- NCT07401160 — Umbilical Cord Drainage to Prevent Postpartum Hemorrhage · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04394455 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Nacional Autonoma de Honduras
- Last refreshed: 2 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04394455.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing